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Photoluminescent carbon dots (C-dots) were prepared using the improved nitric acid oxidation method. The C-dots
were characterized by tapping-mode atomic force microscopy, and UV–vis absorption spectroscopy. The C-dots
were subjected to systematic safety evaluation via acute toxicity, subacute toxicity, and genotoxicity experiments
(including mouse bone marrow micronuclear test and Salmonella typhimurium mutagenicity test). The results
showed that the C-dots were successfully prepared with good stability, high dispersibility, and water solubility. At all
studied C-dot dosages, no significant toxic effect, i.e., no abnormality or lesion, was observed in the organs of the
animals. Therefore, the C-dots are non-toxic to mice under any dose and have potential use in fluorescence
imaging in vivo, tumor cell tracking, and others.
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The importance of fluorescent nanoprobes in biomedical
research and practice is rapidly increasing with the rapid
developments in fluorescence microscopy, laser tech-
nologies, and nanotechnology. Fluorescent carbon dots
(C-dots), a novel form of nanocarbon, have the inherent
properties of traditional semiconductor-based quantum
dots (e.g., size- and wavelength-dependent luminescence
emissions, resistance to photobleaching, and ease of bio-
conjugation). Apart from these properties, C-dots also
possess special features such as physicochemical stabil-
ity, photochemical stability, and non-blinking behavior
[1-3]. The preparation methods of C-dots are relatively
simple, low cost, and applicable in large scales. Numer-
ous approaches for synthesizing C-dots have been pro-
posed, including dry methods (arc discharge [4,5] and
laser ablation [6]) and solution methods (combustion/
thermal [7-9], electrochemical oxidation [10], organic syn-
thesis [11], and microwave methods [12-14]). C-dots are
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in any medium, provided the original work is pbased quantum dots used in biological imaging in vitro
and in vivo [6,15-22] and have attracted significant atten-
tion since the pioneering work of Sun et al. [20,21].
Although carbon is not considered as an intrinsically
toxic element, the specific material configurations and
structures of C-dots may be potential risks to human
health, thereby raising public concern [22]. Many toxic-
ity evaluations have been conducted for various carbon
nanomaterials in recent years, and the results of the dif-
ferent methods are discrepant [23-34]. The current work
aimed to study systematically the toxicity of C-dot solu-
tion exposure in rats and mice by biochemical and
hematological analyses. C-dots are found to have the
advantages of chemical inertness, low cytotoxicity, and
good biocompatibility.Main text
Materials and methods
Preparation and characterization of carbon nanodots
C-dots were prepared using the improved nitric acid oxi-
dation method. In a typical experiment, 0.5 g of raw soot
(purchased from Jixi Kaiwen Hu, Co., Ltd., Jixi, China)
was placed in acetone solution, ultrasonically cleaned for
30 min, centrifuged to discard the upper yellow solution,
and then dried under a vacuum at 80°C. Subsequently,
the cleaned soot was refluxed in 25 mL of 5 M HNO3 at
120°C for 12 to 18 h until a homogeneous black aqueousn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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trifuged at 3,000 rpm for 10 min to remove unreacted
precipitates. The light-brown solution was collected, neu-
tralized, and extensively dialyzed with an MWCO-1000
membrane against pure water. The suspended solution
was precipitated by adding acetone and centrifuged at
14,000 rpm for 10 min. Size separation was performed in
a water/ethanol/chloroform solvent mixture by high-
speed (8,000 to 10,000 rpm) stepwise centrifugation. The
supernatant was collected after spinning at 10,000 rpm,
and the precipitate was discarded. Finally, a yellow solu-
tion of C-dots with 1- to 3-nm particle sizes was obtained.
The C-dots were passivated with a PEG2000N solution at
140°C under the protection of nitrogen gas for 72 h. The
dots were then dialyzed using an MCO 3000 dialysis
membrane to remove excess PEG2000N.
Tapping-mode (TM)-atomic force microscopy (AFM) im-
ages of the C-dots -NH2 were taken using a MultiMode
Nanoscope IIIa scanning probe microscopy system (Veeco
Instruments Inc., Plainview, NY, USA). Commercially avail-
able AFM cantilever tips with a force constant of approxi-
mately 48 N/m and a resonance vibration frequency of
approximately 330 kHz were used. The scanning rate was
set to 1 to 1.5 Hz. The samples for TM-AFM were prepared
by dropping an aqueous suspension (0.01 mg/mL) of
C-dots NH2 on a freshly cleaved mica surface and drying
under a vacuum at 80°C. UV–vis spectra were obtained
at 20°C using a Shimadzu UV-2450 UV–vis spectrophotom-
eter (Shimadzu Corporation, Kyoto, Japan) equipped with a
10-mm quartz cell and with a light path length of 1 cm.
Fluorescence spectra were obtained using a Hitachi FL-4600
spectrofluorimeter (Hitachi Ltd., Tokyo, Japan).
Experimental animals
Systematic safety evaluation experiments (acute toxicity,
subacute toxicity, and genotoxicity experiments, includingFigure 1 Image, analysis, and spectra of C-dots-NH2. (A) TM-AFM imag
with a white line. (C) UV absorption and photoluminesecence spectra of C
nm with an 8-W UV light.mouse bone marrow micronuclear test and Salmonella
typhimurium mutagenicity (Ames) test) were conducted.
All animal experiments were performed in compliance with
the local ethics committee. Animals were obtained from
the animal laboratories of the Academy of Military Medical
Sciences in compliance with the institutional Animal Care
and Use Program Guidelines. The animals were given food
and water, and housed under 12 h/12 h light/dark cycle.
After acclimation, the animals were randomly divided into
different groups for in vivo toxicity evaluations.
Acute toxicity evaluations
Sixty BALB/c mice (17 to 21 g) were divided into three
groups of 20 each for tail injections to test for acute tox-
icity. Each group had 10 female and 10 male mice that
were intravenously exposed to C-dots through a single
tail injection of either 5.1 or 51 mg/kg body weight
(BW). Other mice were injected with 0.9% NaCl aqueous
solution to serve as the control group. Within 14 days
of monitoring, the body weights of the mice were
measured. At various time points (3 and 14 days after
exposure), 10 mice (5 males and 5 females) per time
point were sacrificed. Blood samples were collected from
each mouse for blood chemistry tests and complete
blood panel analysis. Statistical calculations were based
on the standard deviations of 10 mice per group.
Subacute toxicity evaluations
Sixty-four Wistar rats (177 to 224 g) were randomly
divided into three test groups (low, medium, or high
dose) and one control group with 16 rats in each group
(8 males and 8 females). The low, medium, and high
doses (0.2, 2, and 20 mg/kg BW) of C-dots were admin-
istered as a single tail vein injection. The rats in the con-
trol group were exposed to 0.9% NaCl aqueous solution.
At 1, 3, 7, and 28 days after exposure, blood from eache of C-dots-NH2. (B) The section analysis selected the site in (A) labeled
-dots-NH2 in pure water, the inset of the photography excited at 302
Table 1 Body weight of mouse treated with different
doses of carbon dots
Days Dose Female (n = 5) Male (n = 5) Total (n = 10)
Day 0-1 Control 18.8 ± 0.8 18.6 ± 0.5 18.7 ± 0.7
Low 18.0 ± 0.7 18.1 ± 0.7 18.0 ± 0.6
High 18.6 ± 0.4 18.4 ± 0.5 18.5 ± 0.5
Day 3 Control 17.6 ± 0.4 20.3 ± 0.8 19.0 ± 1.6
Low 18.7 ± 1.2 19.7 ± 0.8 19.2 ± 1.1
High 19.0 ± 1.0 20.4 ± 0.9 19.7 ± 1.2
Day 7 Control 23.0 ± 0.9 21.0 ± 1.2 22.0 ± 1.5
Low 22.6 ± 0.8 20.5 ± 1.0 21.6 ± 1.4
High 23.3 ± 1.2 20.7 ± 0.8 22.0 ± 1.7
Day 14 Control 27.0 ± 1.1 24.7 ± 0.8 25.8 ± 1.5
Low 27.1 ± 1.4 24.1 ± 1.2 25.6 ± 2.0
High 25.6 ± 1.3 22.7 ± 0.6* 24.2 ± 1.8
Table 2 Biochemistry results of mice intravenously













40 ± 8 45 ± 15 43 ± 7 0.597 0.558
Glutamic oxaloacetic
transaminase (U/L)
108 ± 22 111 ± 31 99 ± 15 0.697 0.507
Urea (mmol/L) 8.08 ± 1.79 6.79 ± 1.10 7.13 ± 2.08 1.521 0.237
Creatinine (μmol/L) 30 ± 2 28 ± 3 26 ± 2** 9.367 0.001
Cholesterol (mmol/L) 2.82 ± 0.25 2.68 ± 0.30 2.80 ± 0.50 0.428 0.656
Triglyceride (mmol/L) 1.39 ± 0.68 1.62 ± 0.56 1.44 ± 0.43 0.468 0.632
Blood glucose
(mmol/L)
8.40 ± 1.38 8.17 ± 1.08 7.50 ± 0.80 1.749 0.193
Total protein (g/L) 52.8 ± 4.0 50.8 ± 2.6 51.0 ± 2.4 1.381 0.268
Albumin (g/L) 33.3 ± 3.0 32.0 ± 2.0 31.9 ± 2.2 1.147 0.333
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blood panel analyses before the rats were euthanatized
30 days post-exposure. The major organs (heart, liver,
spleen, stomach, kidneys, lungs, brain, testicles, ovaries,
adrenal glands, and intestines) were collected. For con-
ventional histological analyses, tissues were immediately
collected after the rats were sacrificed, fixed in 10%
formaldehyde, embedded in paraffin, cut into 8-μm
sections, stained with hematoxylin and eosin, and then
examined by light microscopy. The results are pres-
ented as the mean ± SD. Statistical differences were eval-
uated using the variance test and considered significant
at P < 0.05.
Medullary micronucleus test
Fifty healthy Kunming mice (25 to 30 g; equal numbers
of males and females) were randomly divided into two
control groups (positive and negative) and three test
groups. The test groups were injected with low, middle,
and high doses (2.04, 10.2, and 51 mg/kg BW, respec-
tively) of C-dots for the bone marrow micronucleus test.
Mice in the negative control group were exposed to
deionized water via a single tail vein injection. Mice in
the positive control group were treated with 40 mg/kg
BW Cytoxan by intraperitoneal injection in the 30-h
administration method. The sternum of each mouse was
excised and prepared for sectioning. The bone marrow
micronucleus and sperm morphology were observed un-
der an oil lens using an Olympus microscope (Olympus
Corporation, Tokyo, Japan). The results were statistically
evaluated using the chi-square test with significance at
P < 0.01.
S. typhimurium mutagenicity (Ames) test
The extracts and controls were added to nutrient media
inoculated with S. typhimurium (TA97, TA98, TA100,and TA102) with or without the S9 system (in vitro meta-
bolic activation system using S9 mixture). The number of
colonies in each culture dish was scored after 48 h of cell
culture. The plates were divided into four groups: nega-
tive, positive, positive solvent, and test groups. The test
group was added to C-dot media with final doses of
0.0125, 0.025, 0.05, and 0.1 mg/plate.
Discussion
Characteristics of the C-dots
The morphology and sectional analyses of C-dots-NH2
were performed by TM-AFM, and the results are shown in
Figure 1A,B, respectively. The C-dots were quasispherical
and uniform, with diameters ranging from 1 to 3 nm. After
grafting with PEG2000N, the nanoparticle sizes slightly
increased to 3 to 5 nm. The UV–vis absorption and fluo-
rescence emission spectra of C-dots-NH2 are shown in
Figure 1C. The peak and edge of the UV–vis spectra were
at 320 and 450 nm, respectively. At an excitation wave-
length of 370 nm, a strong emission peak at 540 nm was
observed in the photoluminescence emission spectrum of
C-dots-NH2. In addition, we also added the (a) statistical
sizes of C-dots and C-dots-NH2 and (b) Zata potential (see
Additional file 1: Figure S1).
Acute toxicity evaluations
C-dot doses of 5.1 or 51 mg/kg BW did not cause mor-
tality in the exposed mice, and no obvious clinical tox-
icity sign was observed. The female BALB/c mice treated
with C-dots appeared healthy, and their body weight gain
patterns were similar to those of the controls (P > 0.05)
3, 7, and 14 days after exposure. The male BALB/c mice
treated with a high dose of the C-dots showed a significant
difference from the control group 14 days after exposure.
No significant difference was observed 3 and 7 days after
exposure (P > 0.05), as shown in Table 1.
Table 3 Biochemistry results of mice intravenously exposed to C-dots (day 14)
Biochemical index Control (n = 10) Low (n = 10) High (n = 10) F value P value
Glutamate-pyruvate transaminase (U/L) 39 ± 11 41 ± 8 38 ± 8 0.352 0.707
Glutamic oxaloacetic transaminase (U/L) 104 ± 26 104 ± 20 94 ± 16 0.717 0.497
Urea (mmol/L) 7.66 ± 1.02 6.81 ± 1.25 6.87 ± 0.83 2.035 0.150
Creatinine (μmol/L) 24 ± 4 24 ± 3 23 ± 3 0.279 0.759
Cholesterol (mmol/L) 2.65 ± 0.50 2.67 ± 0.45 2.72 ± 0.48 0.050 0.951
Triglyceride (mmol/L) 1.66 ± 0.63 1.51 ± 0.29 1.66 ± 0.30 0.390 0.681
Blood glucose (mmol/L) 9.45 ± 1.33 7.76 ± 0.72** 8.34 ± 0.99* 6.795 0.004
Total protein (g/L) 52.2 ± 2.6 52.9 ± 2.0 52.4 ± 1.6 0.289 0.751
Albumin (g/L) 32.6 ± 0.9 32.6 ± 1.2 32.1 ± 1.2 0.825 0.449
Wang et al. Nanoscale Research Letters 2013, 8:122 Page 4 of 9
http://www.nanoscalereslett.com/content/8/1/122After treatment with carbon dots, the body weight of
the mouse was weighed at different time points after the
administration. Data were mean ± SD. *P < 0.05 com-
pared with control by one-way ANOVA test.
On the third day after exposure, no significant difference
was found among all groups in terms of the glutamic
oxaloacetic transaminase (GOT), glutamate pyruvate trans-
aminase (GPT), urea, cholesterol, triacylglyceride (TG),
blood glucose, total protein, and albumin levels (P > 0.05).
In contrast, the creatinine (Cr) levels in the high-dose
group showed significant differences (P < 0.01), as shown
in Table 2.
The biochemical parameters of mice were determined
3 days after C-dot treatment. Data were mean ± SD.
**P < 0.01 compared with that from mice in the control
group by one-way ANOVA test.
On the 14th day after exposure, no significant differ-
ence was found among all groups in their levels of GOT,
GPT, urea, Cr, cholesterol, TG, total protein, and albumin
(P > 0.05). Blood glucose showed significant differences
from the low-dose (P < 0.01) and high-dose (P < 0.05)
groups compared with the control group (Table 3). The
significant decrease in the blood glucose concentration
may be associated with the long duration of anesthesia.
The biochemical parameters of mice were determined





Female Negative control 8 193.9 ± 8.24 0.327 0.806
Low 8 191.2 ± 7.70
Middle 8 194.4 ± 7.01
High 8 194.6 ± 7.71 2
Male Negative control 8 207.9 ± 7.9 0.970 0.421
Low 8 210.2 ± 7.3
Middle 8 211.4 ± 8.8 2
High 8 205.0 ± 8.4 2*P < 0.05, **P < 0.01 compared with that from mice in
the control group by one-way ANOVA test.Subacute toxicity evaluations
Beginning on the third week of exposure to C-dots, the
body weight of the rats in all groups significantly in-
creased (Table 4). The difference in the body weight
changes of the rats between the negative groups every
week was insignificant (P > 0.05). The food intake and
food utilization of the test groups were not significantly
different between the negative groups (P > 0.05).
Body weight of rats was taken at different time points
after C-dot treatment. Data were mean ± SD. Significant
difference was analyzed by one-way ANOVA test.
To reveal any potential toxic effect of the C-dots on
the treated rats, biochemical and hematological analyses
were performed. The following key hematology markers
were assessed at various time points (1, 3, 7, and 28
days): white blood cells, red blood cells, platelets, lym-
phocytes, neutral cells, other cells, hemoglobin, and
hematocrit (HCT) (Figure 2). All above parameters in
rats treated with different concentrations of C-dots at
different time points appeared to be normal compared
with the control groups. However, 7 days after exposure,








204.5 ± 9.4 222.6 ± 11.6 237.4 ± 16.3 246.9 ± 18.8 0.177 0.911
201.8 ± 9.0 220.0 ± 12.1 237.4 ± 13.4 247.5 ± 12.4
203.4 ± 6.8 219.9 ± 11.0 234.8 ± 13.0 246.0 ± 14.3
04.1 ± 10.4 220.2 ± 14.1 231.9 ± 18.7 241.9 ± 21.2
250.8 ± 9.6 308.4 ± 13.7 344.6 ± 18.4 383.8 ± 25.5 0.590 0.626
246.5 ± 7.7 302.1 ± 12.1 336.4 ± 7.7 373.0 ± 17.4
45.9 ± 14.3 297.5 ± 16.8 336.0 ± 19.1 373.9 ± 26.2
45.4 ± 11.4 308.5 ± 11.6 346.4 ± 15.6 383.6 ± 16.3
Figure 2 Blood hematology analysis of rats treated with C-dots. The rats were treated with C-dots at doses of 0.2, 2, and 20 mg/kg BW in 1, 3, 7
and 28 days. (A) White blood cells, (B) red blood cells, (C) hemoglobin, (D) HCT, (E) platelets, (F) lymphocytes, (G) neutral cells, and (H) other cells.
Figure 3 Changes of the blood biochemical data of rats treated with C-dots. The rats were treated with C-dots at doses of 0.2, 2, and 20
mg/kg BW in 1, 3, 7, and 28 days. (A) GPT, (B) GOT, (C) urea, (D) cholesterol, (E) TG, (F) blood glucose, (G) Cr, (H) total protein, and (I) albumin.
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Figure 4 Results of histopathological analyses of rats. The rats were treated with C-dots at the dose of 20 mg/kg BW at 30 days.
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control group (P < 0.05).
Subacute C-dot poisoning can cause changes in the
following biochemical indices: GOT, GPT, urea, Cr, chol-
esterol, TG, blood glucose, total protein, and albumin
(Figure 3). On the first day after exposure, the blood ar-
senic level in the high-dose group was obviously higher
than in the control group (P < 0.01), and the TG levels
significantly decreased (P < 0.01). Within 30 days after
the first exposure, all biochemical parameters of the rats
treated with different doses of C-dots at different time
points appeared to be normal compared with the control










Female Negative control 235.9 ± 17.2 6.74 ± 0.66 2.86 ± 0.22 0.60
Low 235.8 ± 12.8 6.92 ± 0.53 2.94 ± 0.20 0.59
Middle 234.9 ± 13.9 6.61 ± 0.53 2.83 ± 0.30 0.59
High 230.8 ± 20.6 6.67 ± 0.90 2.88 ± 0.22 0.56
Male Negative control 362.5 ± 22.7 12.52 ± 1.94 3.44 ± 0.34 0.91
Low 352.9 ± 17.8 11.21 ± 1.05 3.18 ± 0.24 0.90
Middle 354.1 ± 27.0 11.22 ± 1.02 3.18 ± 0.30 0.86
High 362.1 ± 15.3 11.16 ± 0.91 3.08 ± 0.26 0.90hematological parameters were statistically different be-
tween the test and negative control group, these differ-
ences were not biologically significant.
The organs of the rats injected with C-dots at the
highest dose of 20 mg/kg BW were harvested for histo-
pathological analysis. These organs included the heart,
liver, spleen, stomach, kidneys, lungs, brain, stomach, in-
testines, ovaries, and testes. As shown in Figure 4, no ob-
vious organ damage was noticed. Likewise, no apparent
histopathological abnormality or lesion in the test groups
was observed. The size and structure of the cardiac
muscle fibers in the test group were uniform and normal.













± 0.07 0.26 ± 0.03 1.78 ± 0.14 0.75 ± 0.05 0.24 ± 0.07 0.10 ± 0.03
± 0.04 0.25 ± 0.02 1.70 ± 0.12 0.72 ± 0.03 0.27 ± 0.05 0.12 ± 0.02
± 0.03 0.25 ± 0.01 1.71 ± 0.09 0.73 ± 0.05 0.25 ± 0.05 0.11 ± 0.02
± 0.07 0.24 ± 0.02 1.76 ± 0.12 0.76 ± 0.03 0.26 ± 0.06 0.11 ± 0.02
± 0.14 0.25 ± 0.04 2.79 ± 0.25 0.77 ± 0.05 3.13 ± 0.13 0.86 ± 0.03
± 0.08 0.25 ± 0.02 2.65 ± 0.23 0.75 ± 0.07 3.19 ± 0.16 0.90 ± 0.06
± 0.10 0.24 ± 0.03 2.61 ± 0.16 0.74 ± 0.05 3.21 ± 0.18 0.91 ± 0.04
± 0.72 0.25 ± 0.02 2.66 ± 0.16 0.73 ± 0.04 3.21 ± 0.19 0.89 ± 0.05
Table 6 Medullary micronucleus results of mice exposed to C-dots





No. X ± S
Female Negative control 5 5 × 1,000 5 1.0 ± 0.7 1.0 1.33 ± 0.18
Low 5 5 × 1,000 4 0.8 ± 0.8 0.8 1.33 ± 0.31
Middle 5 5 × 1,000 4 0.8 ± 0.4 0.8 1.33 ± 0.19
High 5 5 × 1,000 5 1.0 ± 0.7 1.0 1.28 ± 0.19
Positive control 5 5 × 1,000 157 31.4 ± 5.8*** 31.4 0.000 1.23 ± 0.08
Male Negative control 5 5 × 1,000 2 0.4 ± 0.5 0.4 1.41 ± 0.12
Low 5 5 × 1,000 3 0.6 ± 0.5 0.6 1.40 ± 0.08
Middle 5 5 × 1,000 2 0.4 ± 0.5 0.4 1.36 ± 0.11
High 5 5 × 1,000 3 0.6 ± 0.5 0.6 1.41 ± 0.10
Positive control 5 5 × 1,000 163 32.6 ± 6.4*** 32.6 0.000 1.22 ± 0.07
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lobule was normal, with few collagen fibers located in the
portal area and central vein. The splenic capsule was
complete, and the red and white pulps were clear. The lung
structures were normal and no inflammation was found. In
the sections of the kidneys, the glomerular structure was
easily distinguished. No bleeding, ulcer, or abnormal differ-
entiation was observed in the gastric mucosa.
No significant difference was found between the weights
of the major organs (liver, spleen, kidney, ovaries, and tes-
tes) between the test groups (both female and male) and
negative control group (P > 0.05), as shown in Table 5.
The liver, spleen, kidney, and ovary/testis of rats were
separated and weighed. Data were mean ± SD. Signifi-
cant difference was analyzed by one-way ANOVA test.Table 7 Ames test results of mice (revertant colonies)
Dose (mg/plate)
TA97
0.1 −S9 129.3 ± 11.4
+S9 128.7 ± 25.0
0.05 −S9 128.7 ± 15.1
+S9 139.3 ± 8.3
0.025 −S9 131.3 ± 9.0
+S9 142.0 ± 11.1
0.0125 −S9 118.0 ± 13.5
+S9 121.3 ± 11.0
Negative control −S9 135.3 ± 14.7
+S9 131.0 ± 26.5
Positive solvent group −S9 130.3 ± 14.6
+S9 130.7 ± 12.1
Positive control −S9 803.3 ± 165.0
+S9 780.0 ± 177.8Medullary micronucleus test
Table 6 shows that the micronucleus cell frequency (MCF)
of hematopoietic cells in the mouse bone marrow and
the polychromatic erythrocyte/normochromatic erythrocyte
(PCE/NCE) were all within the normal range. The MCF re-
sults of the positive group were higher than that of the
negative group (P < 0.01). All C-dot dosages did not induce
micronucleus formation in the mouse cells.
Data were mean ± SD. ***P < 0.001 compared with that
from the negative control. Significant difference was an-
alyzed by the chi-square test.
S. typhimurium mutagenicity (Ames) test
The results of the Ames test showed that no detectable mu-
tagenicity was caused by the C-dots under the experimentalStrains
TA98 TA100 TA102
32.3 ± 6.7 134.7 ± 20.0 290.0 ± 33.4
38.0 ± 6.9 138.3 ± 13.2 294.0 ± 28.0
33.0 ± 7.8 132.0 ± 16.0 279.3 ± 22.0
35.7 ± 5.5 132.0 ± 18.3 295.7 ± 14.4
33.0 ± 7.2 128.7 ± 12.2 280.0 ± 13.1
40.0 ± 5.3 151.0 ± 13.5 302.3 ± 19.3
33.3 ± 6.4 127.7 ± 19.7 279.3 ± 28.4
34.0 ± 6.5 134.7 ± 16.2 284.3 ± 17.6
31.0 ± 4.6 136.7 ± 24.4 294.0 ± 27.5
41.0 ± 4.0 130.7 ± 18.0 288.7 ± 20.4
33.7 ± 4.2 - 284.0 ± 20.3
34.7 ± 6.1 137.3 ± 13.3 295.3 ± 21.4
893.3 ± 220.3 640.0 ± 91.7 946.7 ± 122.2
1,160.0 ± 183.3 746.7 ± 140.5 1,000.0 ± 208.8
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TA102 were induced by dexon (50 μg/plate), whereas strain
TA100 was treated with sodium azide (1.5 μg/plate) without
the addition of the S-9 system. Strains TA97, TA98, and
TA100 were induced by 2-acetylaminofluroene (5 μg/plate),
whereas strain TA102 was treated with 8-dihydroxy-
anthraquinone (50 μg/plate) when the S-9 system was
added. Except for TA100, all strains were induced positively
by the solvent dimethylsulfoxide with the S-9 system added.
The number of colonies in each culture dish was
scored after 48 h of cell culture. Data were mean ± SD.
Conclusion
In this work, photoluminescent C-dots with good stabil-
ity, water solubility, and high dispersibility were success-
fully prepared. The toxicity of the prepared C-dots was
then systematically evaluated. The results showed that
the fluorescent C-dots at difference doses did not exert
any significant toxic effect on rats and mice under the
doses used in our experiments. No abnormality or lesion
was observed in the major organs of rats treated with
the C-dots. The C-dots also did not exhibit any gene tox-
icity. Thus, the as-prepared C-dots have good biocompati-
bility and potential use in in vivo molecular imaging and
biolabeling, and others.
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